Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAMICTAL Extended-release in Partial Seizures
NCT00113165Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2004
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 3, randomised, double-blind trial in epilepsy comparing LAMICTAL extended-release with Placebo (2 arms). Primary endpoint: Percentage change from Baseline in partial seizure frequency at 24 weeks. Started Oct 2004; status: completed.
02
Drugs
lamotrigine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00113165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00113165.